Sowell Financial Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$851K Buy
10,871
+428
+4% +$29.2K 0.03% 501
2026
Q1
$675K Buy
10,443
+1,289
+14% +$90.9K 0.03% 547
2025
Q4
$616K Buy
9,154
+74
+0.8% +$4.98K 0.02% 580
2025
Q3
$666K Buy
+9,080
New +$603K 0.03% 550
2021
Q2
Sell
-2,704
Closed -$129K 1450
2021
Q1
$129K Sell
2,704
-993
-27% -$45.3K ﹤0.01% 1260
2020
Q4
$158K Sell
3,697
-482
-12% -$17.3K 0.01% 947
2020
Q3
$110K Sell
4,179
-2,319
-36% -$64.6K 0.01% 944
2020
Q2
$174K Buy
6,498
+5,638
+656% +$127K 0.01% 769
2020
Q1
$15K Hold
860
﹤0.01% 1476
2019
Q4
$15K Sell
860
-185
-18% -$3.2K ﹤0.01% 1539
2019
Q3
$16K Buy
+1,045
New +$17.2K ﹤0.01% 1363

Other funds holding HALO

Sowell Financial Services's HALO Position: Q2 2026 in Review

Sowell Financial Services increased its Halozyme (HALO) stake by 4.1% in Q2 2026, buying an estimated $29.2K and bringing the position to 10,871 shares worth $851K. The position accounts for 0.03% of the portfolio, ranked #501.

Sowell Financial Services first reported a position in HALO in Q3 2019 and has held it in 11 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Sowell Financial Services held 10,871 shares of Halozyme worth $851K as of Q2 2026.
  • Sowell Financial Services bought 428 Halozyme shares in Q2 2026, an estimated $29.2K.
  • Halozyme made up 0.03% of Sowell Financial Services's portfolio in Q2 2026, its #501 holding.
  • Sowell Financial Services first reported a position in Halozyme in Q3 2019 and has held it in 11 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.